GL1X · GenesisL1 explorer

Research workbench

Pvhl-elob-eloc COMPLEX_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4- hydroxy-N-(4-(4-methylthiazol-5-YL)BENZYL) pyrrolidine-2-carboxamide bound

Analyse Pvhl-elob-eloc COMPLEX_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4B9K
Type
protein
Length
1,339 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
UniProt
Q15370, Q15369, P40337
Ligands
TG0
Pockets
14 · best druggability 0.53

Structure

x-ray diffraction · 11 distinct chains · 28% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscription elongation factor B polypeptide 2protein10317% helix, 37% strandQ15370
BTranscription elongation factor B polypeptide 1protein8844% helix, 15% strandQ15369
CVon hippel-lindau disease tumor suppressorprotein13822% helix, 30% strandP40337
DTranscription elongation factor B polypeptide 2protein10115% helix, 36% strandQ15370
ETranscription elongation factor B polypeptide 1protein8744% helix, 15% strandQ15369
FVon hippel-lindau disease tumor suppressorprotein14327% helix, 29% strandP40337
G, JTranscription elongation factor B polypeptide 2protein10315% helix, 39% strandQ15370
HTranscription elongation factor B polypeptide 1protein8948% helix, 15% strandQ15369
IVon hippel-lindau disease tumor suppressorprotein14725% helix, 29% strandP40337
KTranscription elongation factor B polypeptide 1protein9146% helix, 14% strandQ15369
LVon hippel-lindau disease tumor suppressorprotein14624% helix, 29% strandP40337

Ligands and binding sites

  • TG0 · (2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide · ligand · 4 copies · chains C, F, I, L
  • ACT · Acetate ion · additive · 8 copies · chains F, H, I, J, K, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1800.530.8422ACT
2590.510.8618empty
31860.500.7622TG0
41690.480.7622TG0
51430.430.7625empty

Interfaces

15 interfaces between chains.

  • J–K · 1159 Ų buried · 14 hydrogen bonds · protein-protein
  • G–H · 1153 Ų buried · 13 hydrogen bonds · protein-protein
  • D–E · 1153 Ų buried · 13 hydrogen bonds · protein-protein
  • K–L · 1139 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 1137 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 13 modified (artifact).

Compared structures

  • 4B9K · pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.